The obtained results indicated that both AG490 and arbutin could alleviate colitis symptoms, downregulate inflammatory indexes, and inhibit the phosphorylation of JAK2 and STAT3 in a mouse colitis model as well as in LPS-induced epithelial and immune cell inflammation models. The gene discussed is STAT3; the disease is colitis.